Hybrid AF -- A Prospective Registry
Hybrid Procedure for the Treatment of Long Standing Persistent Atrial Fibrillation - A Prospective Registry
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Atrial Fibrillation (AF) is a form of rapid irregular heart rhythm that starts in the upper chambers of the heart (called atria) and is often associated with many health problems. It can cause stroke, palpitations and heart failure. The management of long standing (chronic) AF may require additional medications and blood thinners, potentially for life. It may also require procedures where the heart is shocked with an electrical current to restore normal rhythm. Some patients require a procedure called radiofrequency ablation to address the arrhythmia. The purpose of this registry is to collect information on patients undergoing this combination of procedures into a database, and to then use this information for scientific study to improve the treatment of atrial fibrillation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jul 2012
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
July 5, 2012
CompletedFirst Posted
Study publicly available on registry
July 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2015
CompletedApril 22, 2015
April 1, 2015
2.5 years
July 5, 2012
April 20, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Outcomes of patients with persistent Atrial Fibrillation who undergo the standard of care hybrid procedure
2 years
Study Arms (1)
Atrial Fibrillation
Patients with Atrial Fibrillation that undergo standard of care procedure at the University of Kansas Hospital
Interventions
Standard of care procedure as determined by treating physician for Atrial Fibrillation
Eligibility Criteria
Patients undergoing standard of care procedures to treat Atrial Fibrillation at the University of Kansas Hospital
You may qualify if:
- Documented effectiveness failure of at least one Vaughan-Williams Class III AAD
- Persistent AF as defined by the HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
- Absence of significant structural heart disease as demonstrated by a transthoracic echocardiogram (TTE) of all four chambers of the heart, computed tomography (CT) scan or magnetic resonance imaging (MRI) scan within 6 months prior to enrollment
- Absence of left atrial thrombus as documented by an imaging study (e.g., TTE, transesophageal echocardiogram (TEE), thoracic CT scan, MRI, or left atrial angiography) within 30 days prior to procedure
You may not qualify if:
- History of longstanding persistent AF for more than 3 years
- Documented left atrial size of 60 mm or more
- Documented left ventricular ejection fraction (LVEF) less than 40%
- History of cerebrovascular disease, including stroke or transient ischemic attack (TIA) within 6 months prior to enrollment
- Significant underlying structural heart disease requiring surgical or procedural intervention within the last six months of initial procedure
- Known contraindication to anticoagulant therapy, or inability to comply with anticoagulant therapy
- Pregnancy, planned pregnancy (females of childbearing potential must have a negative pregnancy test prior to enrollment and agree not to become pregnant during the trial) or breastfeeding;
- Concomitant procedure planned
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dhanunjaya Lakkireddy, MD, FACClead
- Estechcollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dhanunjaya Lakkireddy, MD, FACC
University of Kansas Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 5, 2012
First Posted
July 10, 2012
Study Start
July 1, 2012
Primary Completion
January 1, 2015
Study Completion
January 1, 2015
Last Updated
April 22, 2015
Record last verified: 2015-04